OBESITY-INDUCED HYPERTENSION: INTERACTION OF NEUROHUMORAL AND RENAL MECHANISMS
By J. Hall, Jussara M. do Carmo, A. D. da Silva, Zhen Wang, Michael E. Hall. Circulation Research, 2015
1,169 citations recorded by the source corpus.
Excess weight gain, especially when associated with increased visceral adiposity, is a major cause of hypertension, accounting for 65–75% of the risk for human primary (essential) hypertension. Increased renal tubular sodium reabsorption impairs pressure natriuresis and plays an important role in initiating obesity hypertension. The mediators of abnormal kidney function and increased blood pressure during development of obesity hypertension include 1) physical compression of the kidneys by fat in and around the kidneys, 2) activation of the renin-angiotensin-aldosterone system (RAAS), and 3) increased sympathetic nervous system (SNS) activity. Activation of the RAAS system is likely due, in part, to renal compression as well as SNS activation. However, obesity also causes mineralocorticoid receptor activation independent of aldosterone or angiotensin II. The mechanisms for SNS activation in obesity have not been fully elucidated but appear to require leptin and activation of the brain melanocortin system. With prolonged obesity and development of target organ injury, especially renal injury, obesity-associated hypertension becomes more difficult to control, often requiring multiple antihypertensive drugs and treatment of other risk factors, including dyslipidemia, insulin resistance and diabetes, and inflammation. Unless effective anti-obesity drugs are developed, the impact of obesity on hypertension and related cardiovascular, renal and metabolic disorders is likely to become even more important in the future as the prevalence of obesity continues to increase.
Subfields: Aquatic Science
View Paper: https://www.semanticscholar.org/paper/a5da0ccc20ef38542b949ef56293f5130a57a7db
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- R. Carey
- D. Lackland
- Federica Zatterale
- S. Gidding
- G. Bakris
- D. Calhoun
- B. Egan
- R. Brook
Citations in the corpus
- Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications (2019, background): “Obesity-induced IR is also linked to a wide cluster of obesity-associated metabolic abnormalities, such as dyslipidemia, non-alcoholic fatty liver disease (NAFLD), hypertension [11], coronary heart disease, and stroke [12].”
- Resistant Hypertension: Detection, Evaluation, and Management (2018, background): “Visceral adiposity in particular plays a fundamental role in causing high BP through a variety of mechanisms culminating in enhanced salt sensitivity, vascular dysfunction, and activation of the sympathetic nervous system and renin-angiotensin system.(148,149) Mounting evidence further supports the ”
- 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. (2024, neutral): “74 Notably, even non-obese patients should be explored for OSAS in cases of resistant hypertension.”